Showing results (31-40 of 82) with videos related to
Sort By:
Pageof 9
Medrxiv : the Preprint Server for Health Sciences|May 1, 2026
Inherited genetic risk factors in young-onset lung cancerMyvizhi Esai Selvan, Bonnie Elyssa Gould Rothberg, Abhijit A Patel, et al.The Journal of Experimental Medicine|May 5, 2017
Two alternate strategies for innate immunity to Epstein-Barr virus: One using NK cells and the other NK cells and γδ T cellsZakia Djaoud, Lisbeth A Guethlein, Amir Horowitz, et al.Biorxiv : the Preprint Server for Biology|February 13, 2023
IL-15 synergizes with CD40 agonist antibodies to induce durable immunity against bladder cancerJeffrey L Wong, Patrick Smith, Juan Angulo-Lozano, et al.Proceedings of the National Academy of Sciences of the United States of America|August 22, 2023
IL-15 synergizes with CD40 agonist antibodies to induce durable immunity against bladder cancerJeffrey L Wong, Patrick Smith, Juan Angulo-Lozano, et al.Journal for Immunotherapy of Cancer|October 19, 2019
Monalizumab: inhibiting the novel immune checkpoint NKG2AThorbald van Hall, Pascale André, Amir Horowitz, et al.Science Immunology|November 22, 2016
Class I HLA haplotypes form two schools that educate NK cells in different waysAmir Horowitz, Zakia Djaoud, Neda Nemat-Gorgani, et al.European Urology Oncology|March 20, 2026
Blood and Urine Circulating Tumor DNA in Urothelial Bladder Cancer: State of the Art and Clinical PerspectiveIgor Duquesne, Isabelle Epelbaum, Doriane Prost, et al.Nature Immunology|July 2, 2024
Pan-cancer profiling of tumor-infiltrating natural killer cells through transcriptional reference mappingHerman Netskar, Aline Pfefferle, Jodie P Goodridge, et al.Proceedings of the National Academy of Sciences of the United States of America|January 25, 2005
Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cellsDouglass Wu, Guo-Wen Xing, Michael A Poles, et al.Biorxiv : the Preprint Server for Biology|September 15, 2025
Lymphangiogenesis driven by VEGF-C reshapes tumor immune landscape and enables tumor eradication by viral immunotherapyRuben Fernandez-Rodriguez, Sara Cuadrado-Castano, Andrew Edwards, et al.Pageof 9